A large Swedish trial finds that AI-assisted mammography detects more breast cancers and reduces future diagnosis rates compared to standard practices.
Key Details
- 1MASAI trial included more than 105,000 women in Sweden between 2021-2022.
- 2AI-supported mammography led to a 12% reduction in subsequent breast cancer diagnoses.
- 3Trial compared AI triage/detection to the standard two-radiologist double reading.
- 4AI was developed/trained on over 200,000 exams from more than 10 countries.
- 5Implementation should be cautious, with monitoring and validated AI tools.
- 6Published in The Lancet; lead author is Dr. Kristina Lång from Lund University.
Why It Matters
This is one of the first randomized controlled trials providing robust evidence that AI can enhance breast cancer screening programs, potentially improving early detection and reducing radiologist workload. These findings could accelerate responsible clinical adoption of AI in mammography.
Source
Radiology Business
Related News
•Radiology Business
AI Analyzes Mammograms to Assess Post-Surgery Breast Cancer Recurrence Risk
A new AI tool predicts likelihood of breast cancer recurrence after surgery using pre-operative mammograms.
•AuntMinnie
AI-Assisted Mammography Improves Cancer Detection and Cuts Workload
AI-supported mammography increases breast cancer detection, reduces interval cancers, and substantially lowers radiologist workload versus standard double reading.
•Radiology Business
Patient Perceptions of AI in Mammography Differ Across Healthcare Settings
A survey of over 900 women reveals substantial variation in acceptance and expectations of AI in mammography depending on healthcare setting and demographics.